Academic Journal
Q2Current Cancer Drug Targets
About Current Cancer Drug Targets
Current Cancer Drug Targets is a scholarly journal published by Bentham Science Publishers. SCImago 2025 lists it in Q2, with an SJR of 0.726 and H-index of 109.
Coverage: 2001-2026. Research categories: Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3); Oncology (Q3).
Source-backed journal facts
Topics in published research
Cancer Mechanisms and Therapy; Cancer, Hypoxia, and Metabolism; Cancer Research and Treatments; Cancer, Lipids, and Metabolism; Cancer Immunotherapy and Biomarkers; Histone Deacetylase Inhibitors Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Barrier Function and Tight Junctions in Tyrosine Kinase Inhibitor-Induced Diarrhoea: A Scoping Review
Nurul Fathiah Hairul Anuar, Amirah Abdul Rahman, Mohammad Johari Ibahim, Awla Mohd Azraai et al.
2026-09-25 · DOI: 10.2174/0115680096498489260907114046Timosaponin AⅢ and Gefitinib Synergistically Inhibit NSCLC by Targeting RAGE/AKT/NF-κB/VEGF Pathway
Mengfei Chen, Ting Xu, Huiting Peng, Hanshuang Cai et al.
2026-09-22 · DOI: 10.2174/0115680096488328260909072155MicroRNA-23C Impacts Hepatocellular Carcinoma Metastasis by Targeting OTUB1
Ya-Nan Ji, Kai Wang, Zhong-Quan Yi, Si-Yu Gu et al.
2026-09-09 · DOI: 10.2174/0115680096457176260827075822Clinicopathological Profiles and Prognosis of Postoperative HER2-Mutant Non-Small Cell Lung Cancer: A Real-World Analysis
Guangjian Yang, Linyan Tian, Xiaoyong Tang, Yan Wang et al.
2026-08-31 · DOI: 10.2174/0115680096450021260709092217MicroRNAs and Their Crosstalk with Oncogenic Pathways in Gastric Cancer
Liushan Wei, Jia Yu, Yan Hu, Shijie Wu et al.
2026-08-31 · DOI: 10.2174/0115680096460380260819114647Computational Identification of Progesterone Receptor Modulators for Breast Cancer through 3D Pharmacophore Screening and MD Simulation of the ChEMBL Database
Shiom Mane, Babaso Udugade, Sachinkumar Patil, Poournima Sankpal et al.
2026-08-24 · DOI: 10.2174/0115680096477138260812060120PBMC‑secreted Sgp130FcH Inhibits Colorectal Cancer Cells and Cholangiocarcinoma: Proof‑of‑Concept Evidence
Khac Cuong Bui, Phuong Linh Thi Nham, Phuong Linh Tran, Dieu Linh Le et al.
2026-08-24 · DOI: 10.2174/0115680096489216260818093438MRPL35 Suppresses Autophagy-Mediated Ferroptosis in Hepatocellular Carcinoma via the AMPK/mTOR Axis
YuLiang Xu, LiShuai Xiao, ZhiHu Shi, Xi Chen et al.
2026-08-22 · DOI: 10.2174/0115680096518429260818072238Ubiquitination–Androgen Receptor Coupling in Prostate Cancer Therapeutics
Gali Sri Venkata Sai Rishma Reddy, Krishna Samanta, Pulak Kar
2026-08-22 · DOI: 10.2174/0115680096502346260817094745Pharmaceutical Potential of Antibody-Drug Conjugate Doublets for Targeted Treatment of Cancers Heterogeneously Expressing RON Receptor Tyrosine Kinase
Durga Puro, Sreedhar Reddy Suthe, Hang-Ping Yao, Ming-Hai Wang et al.
2026-08-21 · DOI: 10.2174/0115680096480901260730062525Multi-Omics Integration and Proteomic Annotation Prioritize FAM174BAssociated Monocyte Remodeling in COPD and Lung Adenocarcinoma
Hailing Chen, Xuefei Yang, Yufeng Zhao, Huaxin Pang et al.
2026-08-13 · DOI: 10.2174/0115680096496204260803073720Targeting Metal-Dependent Cell Death in Cancer: From Molecular Circuitry to Biomarker-Guided Precision Combination Therapy
Xuyang Huang, Xinyue Zhang, Wei Chen, Qi Zhu et al.
2026-08-12 · DOI: 10.2174/0115680096473673260714045019Rewiring Pharmacology: Drug Repurposing as a Precision Tool in Oncology-A Systematic Review
Sakshi Singh, Swaroop K. Pandey, Jagdip S. Sohal
2026-08-11 · DOI: 10.2174/0115680096490928260626131711HE4 Silence Combined with DDP in the Treatment of Ovarian Cancer, Especially Platinum-resistant Ovarian Cancer
Yaxin Zuo, Ruiqin Wang, Yunshu Xu, Xiaodan Zhang et al.
2026-08-10 · DOI: 10.2174/0115680096428971260308193220Leukocyte Receptor Tyrosine Kinase is A Novel Therapeutic Target In B-Cell Acute Lymphoblastic Leukemia
Yujia Tao, Cheng Xing, Pengyu Zhang, Siwei Chen et al.
2026-08-06 · DOI: 10.2174/0115680096478860260729071501MOB1A Promotes the Occurrence and Development of Breast Cancer by Regulating the IL6/JAK/STAT3 Signaling Pathway and Immune Infiltration
Jian Lei, Guan-Qiao Li, Juan Zhou, San-Gang Wu et al.
2026-08-06 · DOI: 10.2174/0115680096482433260731114149Favorable Response to Bevacizumab Plus Capecitabine in a HER2-negative Breast Cancer Patient with Recurrent Brain Metastases: A Case Report
Zihao Zhu, Pengfei Zhao, Luxuan Wang, Chunhui Li et al.
2026-08-06 · DOI: 10.2174/0115680096495957260730114049Gut Bacterium Morganella morganii-Secreted Proteins Promote Colorectal Tumor Progression through CD137 Upregulation via NF-κB Activation
Yuping Niu, Ruihong Xiao, Hui Sun
2026-08-03 · DOI: 10.2174/0115680096490808260728112624CD82-Mediated Loading of VEGF-A into Extracellular Vesicles Contributes to Ovarian Cancer Evasion of Anti-Angiogenic Therapy
Zhuoye Chen, Conghui Wang, Mingxia Xu, Tingjia Zhu et al.
2026-08-03 · DOI: 10.2174/0115680096489072260728103725Integrating Large-Scale Bulk and Single-Cell RNA Sequencing with Machine Learning: Unveiling the Cytokine Landscape of Glioblastoma and Constructing a Prognostic Feature Model
Longxiao Zhang, Xinyang Yan, Yunfei Zhou, Zhongbo Yang et al.
2026-07-28 · DOI: 10.2174/0115680096458777260720110043Reviews
Community Reviews
Version History
October 4, 2026 at 9:07 pm
October 2, 2026